This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Affymetrix Names GenoSplice As Its Preferred Data Analysis Service Provider Increasing Accessibility For Bioinformatics In Genomic Research

Affymetrix, Inc. (NASDAQ:AFFX) announced a co-marketing agreement today naming GenoSplice, Inc. as its preferred data analysis service provider for the new GeneChip® Human Transcriptome Array 2.0, the most comprehensive microarray available for alternative splicing detection. GenoSplice, a leader in genomic data analysis and alternative splicing, has developed a dedicated expression analysis solution, EASANA ®, including analysis for Affymetrix’ microarrays, such as GeneChip ® Exon 1.0 ST Array, GeneChip ® Human Transcriptome Array 1.0, and the new GeneChip ® Human Transcriptome Array 2.0. When combined with GenoSplice analysis services, these arrays provide the highest resolution profiling of the transcriptome available on a microarray at both the gene and exon level.

“As part of Affymetrix’ commitment to provide end-to-end solutions, we are enabling those without access to bioinformatics to utilize the most powerful microarrays ever developed for the interrogation of alternative splicing events. Now with so many options open to researchers, it is increasingly more important to provide tools that generate biologically relevant results, not just data,” commented Kevin Cannon, SVP – Expression Business Unit at Affymetrix.

“We’re pleased to work with Affymetrix to combine two very powerful tools, Affymetrix’ high resolution microarrays for gene expression profiling of transcript isoforms and GenoSplice’s proprietary transcriptome data analysis service, to help researchers save valuable time so they can focus on the biology instead of on analytical details,” said Marc Rajaud, Co-CEO of GenoSplice. “GeneChip ® Human Transcriptome Array 2.0 increases accessibility to genomic research, resulting in new data that have to be interpreted to be useful. Collaborating with Affymetrix helps keep GenoSplice on the forefront of developing dedicated tools that streamline and simplify genomic data analysis.”

PLEASE NOTE: Affymetrix ®, the Affymetrix logo, and GeneChip ® trademarks are the property of Affymetrix, Inc. All other trademarks are the property of their respective owners.

Products mentioned in this release are For Research Use only. Not for diagnostic procedures.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.10 -1.80%
FB $116.45 -0.24%
GOOG $690.69 -0.05%
TSLA $238.54 -3.70%
YHOO $36.32 -0.75%


Chart of I:DJI
DOW 17,689.65 -141.11 -0.79%
S&P 500 2,056.73 -19.08 -0.92%
NASDAQ 4,760.8580 -44.4330 -0.92%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs